The agreement gives Biomet exclusive global distribution rights to the cranial device, as well as OsteoFab craniomxillofacial implants. The OsteoFab technology uses a type of PEEK polymer that is biocompatible to bone and an additive manufacturing process to 3-D print.
More Articles on Devices:
13 Spine Devices Receive FDA 510(k) Clearance in March
5 Thoughts on Physician-Owned Distributorships
Orthofix Names Emily Buxton as CFO
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
